YAP1信号与癌症:分子通路揭示了新的准机会
Jialin Wu1,2,3, Bonan Chen1,2,3, Fuda Xie1,2,3
1Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
河马路径,特别是YAP1/TAZ激活,驱动癌症的进展和转移. 准这种途径显示出治疗的希望,但需要谨慎的策略来管理其在组织修复和干性的双重作用.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 河马通路对于组织平衡和器官大小调节至关重要.
- YAP1/TAZ激活通过增强瘤细胞存活率和免疫规避来促进瘤发生,转移和化学抵抗.
研究的目的:
- 审查目前对YAP1/TAZ在瘤开始和进展中的作用的理解.
- 评估针对YAP1/TAZ-TEAD复合体的治疗策略.
主要方法:
- 文献综述综合了YAP1/TAZ研究中的当前进展.
- 评估新兴的治疗方法和挑战.
主要成果:
- YAP1/TAZ维持癌症干细胞的特性,表皮细胞转变为介质细胞,以及免疫抑制瘤微环境.
- 小分子干扰TEAD自动棕化是新兴的治疗点.
结论:
- 针对YAP1/TAZ信号提供治疗潜力,但由于YAP1在组织修复中的作用,需要选择性干预.
- 组合疗法和生物标志物的开发对于最大限度地提高疗效和最大限度地降低毒性至关重要.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
相关概念视频
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
